IRIS
BRISIGOTTI, VALERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.984
EU - Europa 1.254
AS - Asia 929
SA - Sud America 238
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.501
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.948
SG - Singapore 384
CN - Cina 269
IT - Italia 253
BR - Brasile 207
SE - Svezia 147
RU - Federazione Russa 140
IE - Irlanda 133
DE - Germania 129
UA - Ucraina 121
FR - Francia 116
HK - Hong Kong 82
VN - Vietnam 69
GB - Regno Unito 63
CI - Costa d'Avorio 55
FI - Finlandia 42
DK - Danimarca 33
IN - India 33
TR - Turchia 33
NL - Olanda 18
ZA - Sudafrica 18
CA - Canada 17
KR - Corea 17
MX - Messico 16
JP - Giappone 14
MA - Marocco 14
AR - Argentina 13
BE - Belgio 13
PL - Polonia 12
ES - Italia 9
BD - Bangladesh 8
AT - Austria 6
IQ - Iraq 6
CL - Cile 5
EC - Ecuador 5
PK - Pakistan 5
CZ - Repubblica Ceca 4
HU - Ungheria 4
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
AE - Emirati Arabi Uniti 2
ID - Indonesia 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
SM - San Marino 2
VE - Venezuela 2
AU - Australia 1
BB - Barbados 1
CO - Colombia 1
JM - Giamaica 1
KE - Kenya 1
MT - Malta 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.501
Salva come PNG Salva come JPEG
Città #
Chandler 372
Ashburn 335
Singapore 248
Dallas 219
Des Moines 185
Fairfield 173
Jacksonville 140
Dublin 133
Boardman 114
New York 109
Wilmington 86
Hong Kong 82
Seattle 82
Woodbridge 73
Houston 67
Cambridge 59
Beijing 58
Munich 57
Abidjan 54
Lawrence 52
Princeton 52
Los Angeles 51
Ann Arbor 50
San Mateo 41
The Dalles 39
Council Bluffs 35
Centro 31
Moscow 29
Turin 26
Turku 24
Ho Chi Minh City 23
San Diego 22
Ancona 21
Pune 21
Shanghai 21
Buffalo 20
São Paulo 20
Guangzhou 19
London 19
Hefei 16
Chicago 15
Tolentino 14
Brussels 13
Hanoi 13
Johannesburg 13
Marche 13
Wuhan 13
Brooklyn 12
Santa Clara 12
Washington 10
Denver 9
Poplar 9
Tokyo 9
Warsaw 9
Ascoli Piceno 8
Chennai 8
Rome 8
Menlo Park 7
Montreal 7
Norwalk 7
Stockholm 7
Boston 6
Cagliari 6
Columbus 6
Helsinki 6
Kilburn 6
Orem 6
Atlanta 5
Curitiba 5
Guarulhos 5
Haiphong 5
Huskvarna 5
Itaquaquecetuba 5
Nuremberg 5
Phoenix 5
Rio de Janeiro 5
Salt Lake City 5
San Francisco 5
Wuxi 5
Frankfurt am Main 4
Gainesville 4
Hangzhou 4
Hanover 4
Redwood City 4
San Bernardo 4
Urbisaglia 4
Boydton 3
Brasília 3
Campinas 3
Civitanova Marche 3
Da Nang 3
Fuzhou 3
Genoa 3
Goiânia 3
Jiaxing 3
Mexico City 3
Milan 3
New Bedfont 3
Pescara 3
Porto Alegre 3
Totale 3.660
Salva come PNG Salva come JPEG
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 271
I polimorfismi genetici nel melanoma cutaneo 177
Involvement of the oral cavity in psoriasis: results of a clinical study 140
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 136
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 127
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 120
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 118
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 115
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 114
Dermoscopic features of conjunctival melanocytic lesions 113
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 113
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 112
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 111
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 110
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 109
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 108
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 104
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 102
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 102
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 102
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 101
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 100
Reticulated acanthoma with sebaceous differentiation 100
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 99
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 99
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 98
The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region 97
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 97
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 96
The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients 95
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 95
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 95
The switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group 92
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 92
Topical application of fumaric acid esters improves appearance of nail psoriasis 92
Mycosis Fungoides-like Eruption and Infliximab 91
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 88
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 88
Relapsing acute generalized exanthematous pustolosis: a guess. 88
Expression of nicotinamide N-methyltransferase in non-melanoma skin cancers 88
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 87
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 87
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 86
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 84
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 82
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 80
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 79
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 74
Phototherapy in Dermatology 73
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 72
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 69
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 67
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 65
Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa 61
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 56
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 56
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 55
Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation. 31
Totale 5.659
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021457 0 0 0 0 0 73 105 27 47 65 108 32
2021/2022425 12 75 22 9 16 24 12 40 23 11 72 109
2022/20231.054 81 125 82 89 56 273 3 57 193 5 68 22
2023/2024601 89 11 57 63 71 141 11 27 4 43 7 77
2024/20251.014 155 81 29 19 39 40 88 33 202 67 140 121
2025/20261.415 289 169 238 310 374 35 0 0 0 0 0 0
Totale 5.659